Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Nusano

Nusano produces over 40 radioisotope types for healthcare and energy sectors using its proprietary, highly efficient production platform.

Secondary Market Price

Updated: 
Jan 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
Company Valuation
Updated: 
Jan 2026
Biomedical
Industry
Valencia, CA
Headquarters
2015
Year Founded
180+
Employee Count

How Nusano Measures Up

To help you manage your Nusano equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

Series C

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

Est val
--
Jan 20, 2026

Create a free account to unlock real-time secondary market prices and future projections of Nusano's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Nusano Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Nusano's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Nusano is a company that develops and supplies radioisotopes for healthcare, clean energy, and critical minerals processing. The company is building a production facility in West Valley City, Utah, to manufacture these materials. Using a proprietary ion source and production platform, Nusano can produce more than 40 varieties of radioisotopes, with applications ranging from cancer therapies to High-Assay Low-Enriched Uranium (HALEU) nuclear fuel. While specific details about the company's founding are not available, its history involves the development of its patented technologies for radioisotope production.

The company's future plans are centered on its Utah production facility, which is designed for scalable and efficient manufacturing. Recent company activities include a non-binding memorandum of understanding with Anson for a lithium chloride offtake agreement and a collaboration with Quantum to advance critical mineral refining. Nusano has also received a “Best Companies to Work For” award from Utah Business and an “Innovation Impact Award” from BioUtah.

Nusano Notable Investors

  • The Wasatch Group
  • S32
  • Verily
  • American Cancer Society’s BrightEdge

Nusano Founders

  • Co-Founder, Howard C. Lewin
  • Co-Founder, Glenn B. Rosenthal

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Nusano worth joining?

Deciding whether to join a company like Nusano depends on your personal career goals and financial situation. Tools like Prospect can help you analyze the value of your potential equity and compare your offer to others in the industry.

What should I do with my Nusano stock?

Managing private company stock involves complex decisions about when to exercise options, pay taxes, and sell shares. Platforms like Prospect offer personalized strategies to help you optimize the value of your equity and navigate these choices.

Can you sell Nusano stock?

Selling stock in a private company like Nusano is often possible during specific liquidity events, such as company-approved tender offers or on secondary markets. Tools like Prospect can help you navigate these opportunities by determining how much to sell and which shares are most tax-efficient.

How can I find the value of my Nusano stock?

Valuing stock in a private company is challenging because it isn't traded on a public exchange. You can use platforms like Prospect, which uses predictive models and proprietary data to help forecast the future value of your shares.

What is Nusano's equity worth?

The precise value of Nusano's equity will remain uncertain until a liquidity event like an IPO, acquisition, or a new funding round that sets a new valuation. To get an informed estimate, you can use services like Prospect which project a range of potential outcomes for your equity.

What is Nusano's stock ticker symbol?

As a private company, Nusano does not have a stock ticker symbol because it is not traded on a public stock exchange. Ticker symbols are assigned to companies only when they undergo an initial public offering (IPO).

Can I buy or sell Nusano stock?

Buying shares in a private company like Nusano is typically limited to accredited investors or employees exercising their stock options. Selling is usually possible only during specific events like tender offers, and platforms like Prospect offer tools to help you make informed decisions during these opportunities.

What is the criteria to buy or invest in Nusano stock?

Investing in a private startup like Nusano is typically reserved for venture capital firms and accredited investors during formal fundraising rounds. Employees may also acquire equity as part of their compensation package by exercising their stock options.

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?